BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10856685)

  • 1. Point dose variations with time during traditional brachytherapy for cervical carcinoma.
    King GC; Bloomer WD; Kalnicki S; Faul CM; Gooding WE; Stockstill TF; Wu A; Buchsbaum R; Chen AS; Gerszten K; Kalend A
    Med Dosim; 2000; 25(2):77-80. PubMed ID: 10856685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CT based 3-dimensional treatment planning of intracavitary brachytherapy for cancer of the cervix: comparison between dose-volume histograms and ICRU point doses to the rectum and bladder.
    Hashim N; Jamalludin Z; Ung NM; Ho GF; Malik RA; Phua VC
    Asian Pac J Cancer Prev; 2014; 15(13):5259-64. PubMed ID: 25040985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dosimetry methods in determining radiation dosage of the rectum in HDR-brachytherapy of cervix carcinoma].
    Eich HT; Haverkamp U; Micke O; Prott FJ; Pötter R
    Strahlenther Onkol; 1998 Jul; 174(7):375-80. PubMed ID: 9689959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between CT-based volumetric calculations and ICRU reference-point estimates of radiation doses delivered to bladder and rectum during intracavitary radiotherapy for cervical cancer.
    Pelloski CE; Palmer M; Chronowski GM; Jhingran A; Horton J; Eifel PJ
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):131-7. PubMed ID: 15850913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in applicator positions and dose distribution between high dose rate brachytherapy fractions in cervix carcinoma patients receiving definitive radiotherapy.
    Garipağaoğlu M; Tunçel N; Dalmaz MG; Gülkesen H; Toy A; Kizildağ AU; Köseoğlu FG
    Br J Radiol; 2006 Jun; 79(942):504-9. PubMed ID: 16714753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of "optimized" treatment planning for tandem and ring, and tandem and ovoids, using high dose rate brachytherapy for cervical cancer.
    Noyes WR; Peters NE; Thomadsen BR; Fowler JF; Buchler DA; Stitt JA; Kinsella TJ
    Int J Radiat Oncol Biol Phys; 1995 Jan; 31(1):79-86. PubMed ID: 7995771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison between tandem and ovoids and interstitial gynecologic template brachytherapy dosimetry using a hypothetical computer model.
    Hsu IC; Speight J; Hai J; Vigneault E; Phillips T; Pouliot J
    Int J Radiat Oncol Biol Phys; 2002 Feb; 52(2):538-43. PubMed ID: 11872302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dosimetry of intracavitary placements for uterine and cervical carcinoma: results of orthogonal film, TLD, and CT-assisted techniques.
    Kapp KS; Stuecklschweiger GF; Kapp DS; Hackl AG
    Radiother Oncol; 1992 Jul; 24(3):137-46. PubMed ID: 1410567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Point vs. volumetric bladder and rectal doses in combined intracavitary-interstitial high-dose-rate brachytherapy: correlation and comparison with published Vienna applicator data.
    Yaparpalvi R; Mutyala S; Gorla GR; Butler J; Mah D; Garg MK; Kalnicki S
    Brachytherapy; 2008; 7(4):336-42. PubMed ID: 18782683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positional stability of sources during low-dose-rate brachytherapy for cervical carcinoma.
    Corn BW; Galvin JM; Soffen EM; Henze G; Schwaibold F
    Int J Radiat Oncol Biol Phys; 1993 Jun; 26(3):513-8. PubMed ID: 8514546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of intracavitary brachytherapy parameters and correlation with outcome in patients with carcinoma of the cervix.
    Katz A; Eifel PJ
    Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1417-25. PubMed ID: 11121642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Geometric and dosimetric variations of ICRU bladder and rectum reference points in vaginal cuff brachytherapy using ovoids.
    Garipagaoglu M; Tuncel N; Köseoglu FG; Gülkesen H; Kizildag AU; Toy A; Dalmaz MG
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1607-15. PubMed ID: 15050342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosimetric analysis at ICRU reference points in HDR-brachytherapy of cervical carcinoma.
    Eich HT; Haverkamp U; Micke O; Prott FJ; Müller RP
    Rontgenpraxis; 2000; 53(2):62-6. PubMed ID: 10994367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of radiography- and computed tomography-based treatment planning in cervix cancer in brachytherapy with specific attention to some quality assurance aspects.
    Fellner C; Pötter R; Knocke TH; Wambersie A
    Radiother Oncol; 2001 Jan; 58(1):53-62. PubMed ID: 11165682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
    Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H
    Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rectal complications in patients with carcinoma of the cervix treated with concomitant cisplatin and external beam irradiation with high dose rate brachytherapy: a dosimetric analysis.
    Clark BG; Souhami L; Roman TN; Evans MD; Pla C
    Int J Radiat Oncol Biol Phys; 1994 Mar; 28(5):1243-50. PubMed ID: 8175412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High dose rate (HDR) brachytherapy technique: for carcinoma of uterine cervix using Nucletron applicators.
    Nair MT; Cheng MC; Barker A; Rouse BS
    Med Dosim; 1995; 20(3):201-7. PubMed ID: 7576095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spatial reproducibility of the ring and tandem high-dose rate cervix applicator.
    Bahena JH; Martinez A; Yan D; Mele E; Edmunson G; Brown D; Hardy M; Brabbins D; Gustafson G
    Int J Radiat Oncol Biol Phys; 1998 Apr; 41(1):13-9. PubMed ID: 9588912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined intracavitary and interstitial brachytherapy of cervical cancer using the novel hybrid applicator Venezia: Clinical feasibility and initial results.
    Walter F; Maihöfer C; Schüttrumpf L; Well J; Burges A; Ertl-Wagner B; Mahner S; Belka C; Gallwas J; Corradini S
    Brachytherapy; 2018; 17(5):775-781. PubMed ID: 29941345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosimetric analysis in brachytherapy of carcinoma of the cervix.
    Krishnan L; Cytacki EP; Wolf CD; Reddy EK; Gemer LS; Giri PG; Smalley SR; Evans RG
    Int J Radiat Oncol Biol Phys; 1990 Apr; 18(4):965-70. PubMed ID: 2323982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.